Hemophilia B Gene Therapy With AAV8 Vector
Clinical trial NCT01620801 · TERMINATED
Trial details
- NCT number
- NCT01620801
- Sponsor
- Spark Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-03-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.